Yasinalli Tamboli

Riyadh, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

T-type calcium channel blockers: a review of recent advances (2018-2025).

T-type calcium channel blockers: a review of recent advances (2018-2025).

Journal: Expert opinion on therapeutic patents

Published: August 01, 2026

Clinical Characterization, Functional Analysis, Gene Therapy, and Management of Rare Genetic Disorders.

Clinical Characterization, Functional Analysis, Gene Therapy, and Management of Rare Genetic Disorders.

Journal: Current medicinal chemistry

Published: June 29, 2026

Molecular Pharmacology of T-Type Calcium Channels and Their Roles in Neurological Disorders.

Molecular Pharmacology of T-Type Calcium Channels and Their Roles in Neurological Disorders.

Journal: Medicinal research reviews

Published: October 28, 2025

Novel benzimidazole-1, 3, 4-thiadiazole derivatives as casein kinase-2 inhibitors: synthesis, in vitro and in silico investigations.

Novel benzimidazole-1, 3, 4-thiadiazole derivatives as casein kinase-2 inhibitors: synthesis, in vitro and in silico investigations.

Journal: BMC chemistry

Published: February 26, 2025

Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms.

Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms.

Journal: ChemMedChem

Published: August 03, 2024

Lasamide, a Potent Human Carbonic Anhydrase Inhibitor from the Market: Inhibition Profiling and Crystallographic Studies.

Lasamide, a Potent Human Carbonic Anhydrase Inhibitor from the Market: Inhibition Profiling and Crystallographic Studies.

Journal: ACS medicinal chemistry letters

Published: July 15, 2024

Novel 2,4-Dichloro-5-sulfamoylbenzoic Acid Oxime Esters: First Studies as Potential Human Carbonic Anhydrase Inhibitors.

Novel 2,4-Dichloro-5-sulfamoylbenzoic Acid Oxime Esters: First Studies as Potential Human Carbonic Anhydrase Inhibitors.

Journal: ACS medicinal chemistry letters

Published: May 01, 2024

High-throughput computational screening for identification of potential hits against bacterial Acriflavine resistance protein B (AcrB) efflux pump.

High-throughput computational screening for identification of potential hits against bacterial Acriflavine resistance protein B (AcrB) efflux pump.

Journal: Journal of biomolecular structure & dynamics

Published: January 24, 2024

Identification of potential biogenic chalcones against antibiotic resistant efflux pump (AcrB) via computational study.

Identification of potential biogenic chalcones against antibiotic resistant efflux pump (AcrB) via computational study.

Journal: Journal of biomolecular structure & dynamics

Published: June 21, 2023

Design and characterisation of piperazine-benzofuran integrated dinitrobenzenesulfonamide as Mycobacterium tuberculosis H37Rv strain inhibitors.

Design and characterisation of piperazine-benzofuran integrated dinitrobenzenesulfonamide as Mycobacterium tuberculosis H37Rv strain inhibitors.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: July 30, 2021

Design and in silico investigation of novel Maraviroc analogues as dual inhibition of CCR-5/SARS-CoV-2 Mpro.

Design and in silico investigation of novel Maraviroc analogues as dual inhibition of CCR-5/SARS-CoV-2 Mpro.

Journal: Journal of biomolecular structure & dynamics

Published: July 26, 2021

Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis.

Potential of NO donor furoxan as SARS-CoV-2 main protease (Mpro) inhibitors: in silico analysis.

Journal: Journal of biomolecular structure & dynamics

Published: July 10, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026